- Home
- ALXO vs CEV Comparison
ALXO vs CEV Comparison
Compare ALXO & CEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALXO
- CEV
- Stock Information
- Founded
- ALXO 2015
- CEV 1999
- Country
- ALXO United States
- CEV United States
- Employees
- ALXO N/A
- CEV N/A
- Industry
- ALXO Biotechnology: Pharmaceutical Preparations
- CEV Finance/Investors Services
- Sector
- ALXO Health Care
- CEV Finance
- Exchange
- ALXO Nasdaq
- CEV Nasdaq
- Market Cap
- ALXO 76.5M
- CEV 71.3M
- IPO Year
- ALXO 2020
- CEV N/A
- Fundamental
- Price
- ALXO $1.74
- CEV $10.06
- Analyst Decision
- ALXO Buy
- CEV
- Analyst Count
- ALXO 6
- CEV 0
- Target Price
- ALXO $11.00
- CEV N/A
- AVG Volume (30 Days)
- ALXO 1.1M
- CEV 19.6K
- Earning Date
- ALXO 03-06-2025
- CEV 01-01-0001
- Dividend Yield
- ALXO N/A
- CEV 4.23%
- EPS Growth
- ALXO N/A
- CEV N/A
- EPS
- ALXO N/A
- CEV 0.36
- Revenue
- ALXO N/A
- CEV N/A
- Revenue This Year
- ALXO N/A
- CEV N/A
- Revenue Next Year
- ALXO N/A
- CEV N/A
- P/E Ratio
- ALXO N/A
- CEV $29.36
- Revenue Growth
- ALXO N/A
- CEV N/A
- 52 Week Low
- ALXO $1.19
- CEV $8.83
- 52 Week High
- ALXO $17.83
- CEV $10.91
- Technical
- Relative Strength Index (RSI)
- ALXO 53.13
- CEV 41.39
- Support Level
- ALXO $1.56
- CEV $9.91
- Resistance Level
- ALXO $1.94
- CEV $10.23
- Average True Range (ATR)
- ALXO 0.16
- CEV 0.06
- MACD
- ALXO -0.01
- CEV 0.01
- Stochastic Oscillator
- ALXO 50.00
- CEV 46.88
About ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
About CEV Eaton Vance California Municipal Income Trust Shares of Beneficial Interest
Eaton Vance CA Muni Income Trust is a non-diversified closed-end investment company. The company's investment objective is to provide current income exempt from regular federal income tax and California state personal income taxes. It invests in municipal obligations, issued by the State of California or its political subdivisions, agencies, authorities and instrumentalities and also has some exposure to corporate bonds.